StockClub

INSD

INSDInstadose Pharma Corp.$ --
Instadose Pharma Corp.

Instadose Pharma Corp.

INSD

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 02/28/2022FY2022 Q1
Revenue
0M USD
YoY -
Operating Income
-1M USD
YoY -7155.3%
Net Income
-1M USD
YoY -7329.4%
EPS
-0$
YoY -10376.2%

Revenue

$0
FY2020 Q2$0
$0
Q2
FY2020 Q3$0
$0
Q3
FY2020 Q4$0
$0
Q4
FY2021 Q1$0
$0
Q1
FY2021 Q2$0
$0
Q2
FY2021 Q3$0
$0
Q3
FY2021 Q4$0
$0
Q4
FY2022 Q1$0
$0
Q1
Actual
$0 (-)

Net Income

$-1.2M
FY2020 Q2$-18,454
$-18,454
Q2
FY2020 Q3$-23,874
$-23,874
Q3
FY2020 Q4$-33,968
$-33,968
Q4
FY2021 Q1$-15,506
$-15,506
Q1
FY2021 Q2$-73,442
$-73,442
Q2
FY2021 Q3$-140,070
$-140,070
Q3
FY2021 Q4$-586,070
$-586,070
Q4
FY2022 Q1$-1.2M
$-1.2M
Q1
Actual
$-1.1M (-7329.4%)

Surprise History

Actual RevenueAnalyst Estimate
FY2016
Actual:$0
FY2016
$0
FY2017
Actual:$0
FY2017
$0
FY2018
Actual:$3,605
FY2018
$3,605
FY2019
Actual:$0
FY2019
$0
FY2020
Actual:$0
FY2020
$0
FY2021
Actual:$0
FY2021
$0

Analyst Estimates

No forecast data